tradingkey.logo

Sarepta Provides Safety Update For Elevidys And Initiates Steps To Strengthen Safety In Non-Ambulatory Individuals With Duchenne

ReutersJun 15, 2025 5:20 AM

- Sarepta Therapeutics Inc SRPT.O:

  • SAREPTA PROVIDES SAFETY UPDATE FOR ELEVIDYS AND INITIATES STEPS TO STRENGTHEN SAFETY IN NON-AMBULATORY INDIVIDUALS WITH DUCHENNE

  • SAREPTA THERAPEUTICS INC - SECOND CASE OF ACUTE LIVER FAILURE RESULTING IN DEATH REPORTED

  • SAREPTA THERAPEUTICS INC - SHIPMENTS OF ELEVIDYS FOR NON-AMBULATORY PATIENTS SUSPENDED

  • SAREPTA THERAPEUTICS INC - ENVISION STUDY PAUSED FOR PROTOCOL AMENDMENT

  • SAREPTA THERAPEUTICS INC - FDA CONCURS WITH PAUSE IN ENVISION STUDY DOSING

  • SAREPTA THERAPEUTICS INC - EVENT REPORTED TO FDA AND GLOBAL HEALTH AUTHORITIES

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI